- Home
- FTK vs ITOS Comparison
FTK vs ITOS Comparison
Compare FTK & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- ITOS
- Stock Information
- Founded
- FTK 1985
- ITOS 2011
- Country
- FTK United States
- ITOS United States
- Employees
- FTK N/A
- ITOS N/A
- Industry
- FTK Major Chemicals
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTK Industrials
- ITOS Health Care
- Exchange
- FTK Nasdaq
- ITOS Nasdaq
- Market Cap
- FTK 440.6M
- ITOS 381.2M
- IPO Year
- FTK N/A
- ITOS 2020
- Fundamental
- Price
- FTK $12.64
- ITOS $10.28
- Analyst Decision
- FTK Buy
- ITOS Hold
- Analyst Count
- FTK 2
- ITOS 6
- Target Price
- FTK $12.00
- ITOS $10.60
- AVG Volume (30 Days)
- FTK 751.7K
- ITOS 773.7K
- Earning Date
- FTK 08-05-2025
- ITOS 08-07-2025
- Dividend Yield
- FTK N/A
- ITOS N/A
- EPS Growth
- FTK 683.07
- ITOS N/A
- EPS
- FTK 0.46
- ITOS N/A
- Revenue
- FTK $202,013,000.00
- ITOS $35,000,000.00
- Revenue This Year
- FTK $15.92
- ITOS N/A
- Revenue Next Year
- FTK $12.67
- ITOS N/A
- P/E Ratio
- FTK $27.89
- ITOS N/A
- Revenue Growth
- FTK 11.96
- ITOS 177.89
- 52 Week Low
- FTK $3.79
- ITOS $4.80
- 52 Week High
- FTK $16.87
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- FTK 37.53
- ITOS 65.14
- Support Level
- FTK $12.56
- ITOS $10.24
- Resistance Level
- FTK $13.50
- ITOS $10.41
- Average True Range (ATR)
- FTK 0.62
- ITOS 0.12
- MACD
- FTK -0.25
- ITOS -0.04
- Stochastic Oscillator
- FTK 15.87
- ITOS 75.00
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.